000 01412 a2200409 4500
005 20250513091606.0
264 0 _c19960729
008 199607s 0 0 eng d
022 _a0091-6749
024 7 _a10.1016/s0091-6749(96)80077-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGustafson, L M
245 0 0 _aOral prednisone therapy in experimental rhinovirus infections.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cApr 1996
300 _a1009-14 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Intranasal
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aCommon Cold
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aKinins
_xmetabolism
650 0 4 _aMale
650 0 4 _aNasal Lavage Fluid
_xchemistry
650 0 4 _aPrednisone
_xtherapeutic use
650 0 4 _aRhinovirus
_xdrug effects
650 0 4 _aSerum Albumin
_xmetabolism
650 0 4 _aSeverity of Illness Index
700 1 _aProud, D
700 1 _aHendley, J O
700 1 _aHayden, F G
700 1 _aGwaltney, J M
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 97
_gno. 4
_gp. 1009-14
856 4 0 _uhttps://doi.org/10.1016/s0091-6749(96)80077-7
_zAvailable from publisher's website
999 _c8654912
_d8654912